Personalized Cannabinoid Therapy Systems with AI, IoT, and Blockchain Integration
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates cannabinoid formulations with AI, IoT, and blockchain technologies to create a personalized, secure, and efficient system for optimizing cannabinoid therapy.
Background and Problem Solved
The original patent disclosed cannabinoid formulations designed to align with an individual's genotype. However, the formulations were limited by the lack of integration with advanced technologies, resulting in inefficiencies in data management, formulation optimization, and patient monitoring. The present inventive concept addresses these limitations by incorporating AI, IoT, and blockchain technologies to create a more powerful and effective system.
Detailed Description of the Inventive Concept
The system comprises a genotype analysis module, a cannabinoid formulation generator, and a blockchain-based secure storage system for storing and managing individualized formulations. The AI-powered formulation generator uses machine learning algorithms to analyze a subject's genotype and medical history, generating a set of potential formulations and selecting an optimal one based on predicted efficacy and safety. The IoT-enabled wearable device monitors cannabinoid effects, transmitting data to a cloud-based server for analysis and personalized recommendations. The blockchain-based platform tracks and verifies the authenticity of cannabinoid formulations, ensuring quality control and certification.
Novelty and Inventive Step
The integration of AI, IoT, and blockchain technologies with cannabinoid formulations is a novel and non-obvious combination that provides a significant improvement over the original patent. The use of AI for formulation optimization, IoT for real-time monitoring, and blockchain for secure data management and authentication represents a new and inventive approach to personalized cannabinoid therapy.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT devices, or blockchain platforms. Variations could include the integration of additional technologies, such as virtual or augmented reality, to enhance the patient experience and improve treatment outcomes.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the cannabis and pharmaceutical industries, with potential applications in personalized medicine, medical research, and patient care. The market for personalized cannabinoid therapy systems is expected to grow rapidly, driven by increasing demand for targeted and effective treatments.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology, specifically cannabinoid formulation design and personalized medicine technologies involving genetic analysis, drug delivery systems, and digital health platforms
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, biotechnology, or biomedical engineering, having expertise in cannabinoid pharmacology, machine learning applications in drug development, and digital health technology integration
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with personalized cannabinoid formulations represents a predictable extension of existing precision medicine approaches. The source patent's focus on genotype-based cannabinoid formulations provides a clear foundation for further technological augmentation. The proposed system's components are well-established in digital health domains and represent logical technological improvements to personalized therapeutic strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,530 |
|---|---|
| Title | Cannabinoid formulations |
| Assignee(s) | Endocanna Health, Inc. |